NCT04266041Completed
High-density EEG in Neurological Disorders
Source: ClinicalTrials.gov · Last updated 12 Dec 2025
Brief summary (registry, in English)
The purpose of the study is to use a new method of high-density electroencephalogram (HD-EEG) recording to map brain areas important for movement, sensation, language, emotion, and cognition.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 122 (actual)
- First submitted
- 10 Feb 2020
- Start date
- 9 Feb 2018
- Primary completion date
- 31 May 2024
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- NCT number
- NCT04266041
What you commit to
- Study type: Interventional
- Participants enrolled: 122
- From 9 Feb 2018 to the primary completion date, 31 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any neurologic or psychiatric diagnosis such as stroke, tumor, or psychosis judged to interfere with high-density EEG.
Who the study is looking for
- Able to perform the tasks
- Able to give own consent
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dartmouth Hitchcock Medical Center Coordinator of this site? Confirm its status | Lebanon | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.